Save information for later
Sign Up

Learn About Henoch-Schonlein Purpura

What is the definition of Henoch-Schonlein Purpura?
Henoch-Schonlein purpura (HSP), also called immunoglobulin A vasculitis (IgAV), is a vascular disease that primarily affects small blood vessels. The disease is characterized by abnormal deposits of immunoglobulin A (an antibody) in the blood vessels, leading to their inflammation (vasculitis). The small vessels of the skin, joints, kidneys, and digestive organs are particularly involved. Signs and symptoms usually begin suddenly (and progress over days) and may include purple-colored spots on the skin (purpura); joint pain; and gastrointestinal problems such as abdominal pain, nausea, bloody stools, and rarely, severe complications requiring surgery. People with HSP may also develop glomerulonephritis (injury to the kidneys caused by inflammation) and poor kidney function, which may result in swelling of parts of the body or face (edema), and blood and protein in the urine (hematuria and proteinuria). Most cases of HSP occur in children and go away without causing serious or long-term health problems. Less commonly, the disease affects adults and may be more severe, leading to chronic kidney disease and kidney failure. The cause of HSP is not completely understood, but research indicates that genes (especially those involved in regulating the immune system) may play a key role in predisposing a person to HSP, as well as its severity. However, while genes may increase the risk of developing the disease (and in some cases more than one family member has HSP), the disease itself is not inherited. The diagnosis of HSP may be made based on symptoms, blood and urine tests, imaging studies, and/or a biopsy of the skin or kidney.
What are the alternative names for Henoch-Schonlein Purpura?
  • Henoch-Schonlein purpura
  • Anaphylactoid purpura
  • Henoch Schonlein purpura
  • Immunoglobulin A vasculitis
  • Immunoglobulin-A vasculitis
  • Purpura, Schonlein-Henoch
  • Vascular purpura
Who are the top Henoch-Schonlein Purpura Local Doctors?
Miguel A. Gay-Gonzalez
Elite in Henoch-Schonlein Purpura
Elite in Henoch-Schonlein Purpura
Rheumatology Div, 
Santander And Univ. Of The Witwatersrand, ZA 

Miguel Gay-Gonzalez practices in Santander And Univ. Of The Witwatersrand, South Africa. Mr. Gay-Gonzalez is rated as an Elite expert by MediFind in the treatment of Henoch-Schonlein Purpura. His top areas of expertise are Vasculitis, Giant Cell Arteritis (GCA), Temporal Arteritis, Lung Transplant, and Kidney Transplant.

Elite in Henoch-Schonlein Purpura
Elite in Henoch-Schonlein Purpura
Turin, IT 

Licia Peruzzi practices in Turin, Italy. Ms. Peruzzi is rated as an Elite expert by MediFind in the treatment of Henoch-Schonlein Purpura. Her top areas of expertise are Henoch-Schonlein Purpura, IgA Nephropathy, Glomerulonephritis, Kidney Transplant, and Liver Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Henoch-Schonlein Purpura
Elite in Henoch-Schonlein Purpura
Turin, IT 

Rosanna Coppo practices in Turin, Italy. Ms. Coppo is rated as an Elite expert by MediFind in the treatment of Henoch-Schonlein Purpura. Her top areas of expertise are IgA Nephropathy, Glomerulonephritis, Henoch-Schonlein Purpura, Purpura, and Kidney Transplant.

What are the latest Henoch-Schonlein Purpura Clinical Trials?
A Phase 3, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Ravulizumab in Pediatric Participants (2 to < 18 Years of Age) With Primary Immunoglobulin A Nephropathy (IgAN)

Summary: The primary objective of this study is to characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of treatment with ravulizumab IV in pediatric participants to support the extrapolation of efficacy from the adult population.

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Vasculitis Pregnancy Registry (V-PREG)

Summary: The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess 1. each woman's vasculitis severity and pregnancy-related experiences, and 2. pregnancy outcomes.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center